NCT01560364

Completed

Bundle Evaluation in Extra Renal Epuration, Incidence of Thr...

University Hospital, Clermont-Ferrand Source

Compare

Other study identifiers

Sponsor study identifier

CHU-0106

Study Type

observational

Actual enrollment (reported)

100

Locations

1 country

Sites

1

Timeline

Study Start

May 2011

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

August 2012

Actual (reported)

Study Completion

August 2012

Actual (reported)

Brief Summary

This is a prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 100 participants
Study completion date: August 2012
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
May 2011
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
October 17, 2011
Actual (reported)
First Posted
March 22, 2012
Actual (reported)
Primary Completion
August 2012
Actual (reported)
Study Completion
August 2012
Actual (reported)

Last Updated: December 2, 2014
Status Verified: November 2014
Last Update Submitted: November 28, 2014

Conditions

Adults Receiving Renal Replacement Therapy

Keywords

Renal replacement therapyHemofilter clottingClotting risk factorHemofilter clotting prevention

Outcome Measures

Primary Outcomes (1)

Hemofilter lifetime
at day 1

Secondary Outcomes (3)

Hemofilter clotting risk factors
at day 1
hemofiltration duration
at day 1
down time value
at day 1

Study Arms (1)

Hemofilter

Other: renal replacement therapy

Interventions

renal replacement therapyOther

Prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Hemofilter

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Adults receiving renal replacement therapy

You may qualify if:

Adult (age \> 18 years)

Sponsors & Collaborators

University Hospital, Clermont-Ferrand
Otherlead

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

MeSH Terms

Interventions

Renal Replacement Therapy

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

Sébastien PERBET
University Hospital, Clermont-Ferrand
PRINCIPAL INVESTIGATOR

Enrollment

100 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 17, 2011

First Posted

March 22, 2012

Study Start

May 2011

Date type not reported

This date has not been verified as actual or estimated.

NCT00322530

Comparison of Dialysis Strategies in Critically Ill Patients With Acute Renal Failure

Not ApplicableCompleted

NCT05382598

Timing of Renal Replacement Therapy In Mechanically Ventilated Patients

Not ApplicableCompleted

NCT02621749

Cerebral Microembolism in the Critically Ill With Acute Kidney Injury

Not ApplicableTerminated

NCT03856723

Predicting Outcomes of Cardiac Surgery-associated Acute Kidney Injury Using Biomarkers At Initiation of RRT

Unknown

NCT03141112

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

Unknown

NCT05182723

Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation

Not ApplicableUnknown

Renal replacement therapy (continuous veino-veinous hemofiltration or continuous veino-veinous hemodiafiltration)

Consent of patients

You may not qualify if:

Use citrate anticoagulation
Age below 18 years

Contact the study team to confirm eligibility.

Primary Completion

August 2012

Actual (reported)

Study Completion

August 2012

Actual (reported)

Last Updated

December 2, 2014

Record last verified: 2014-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01560364
Data provider: ClinicalTrials.gov
Source updated: 2014-12-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:37:31 UTC

Locations

FR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (3)

Study Arms (1)

Hemofilter

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations